Table 2: Effect of chronic administration of Las01 in rats.

Parameters
Control
Las01
Group 1Group 2Group 3

Total WBCcount × 103 mm3
7634 ± 520
7293 ± 488
7335 ± 230
7653 ± 422
Haemoglobin (gm%)
13.13 ± 1.0
12.10 ± 2.85
12.65 ± 1.0
13.16 ± 1.23
Bilirubin total (mg/dL)
0.29 ± 0.12
0.28 ± 0.14
0.30 ± 0.02
0.31 ± 0.12
Bilirubin direct (mg/dL)
0.25 ± 0.15
0.21 ± 0.12
0.28 ± 0.15
0.33 ± 0.14
SGPT (U/L)
45.11 ± 11.12
46.8 ± 10.5
45.66 ± 11.35
44.6 ± 12.1
SGOT (U/L)74.2 ± 12.2573.1 ± 12.674.2 ± 19.33 75.4 ± 14.16
ALP (U/L)210.2 ± 22.5218.3 ± 44.1219.8 ± 42.5228.2 ± 39.5
Albumin (mg/dL)3.27 ± 0.323.31 ± 0.413.26 ± 0.123.25 ± 0.41
Globulin (mg/dL)4.15 ± 0.194.11 ± 0.104.10 ± 0.284.64 ± 0.11
Total protein (gm%)7.32 ± 0.427.42 ± 0.287.36 ± 0.427.89 ± 0.22
BUN (mg/dL)65.12 ± 6.2967.22 ± 6.8764.26 ± 7.0965.15 ± 5.8
Creatinine (mg/dL)0.41 ± 0.020.42 ± 0.030.46 ± 0.010.41 ± 0.06
Sodium (mEq/L)
145.1 ± 2.1144.4 ± 2.39143.6 ± 3.5145.8 ± 2.45
Potassium (mEq/L)
4.8 ± 0. 334.9 ± 0.344.2 ± 0. 764.9 ± 0.01
Chloride (mEq/L)104.1 ± 1.10108 ± 1.08103.5 ± 4.20104.6 ± 1.34